Skip to main content
. 2021 Mar 4;2021(3):CD008726. doi: 10.1002/14651858.CD008726.pub3

11.11. Analysis.

11.11

Comparison 11: Minimally antistaphylococcal cephalosporins C3 (3rd generation) vs broad spectrum penicillins plus betalactamase inhibitors P2+ ‐ all outcomes, Outcome 11: Maternal skin rash